Superworth

ASTROTECH EPS ASTC

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Dec 31, 2021
−$7.50
Latest quarter, Q2 FY22
−$1.50
Fiscal year 2021
−$15.90

ASTROTECH's earnings per share was −$7.50 over the twelve months to Dec 31, 2021.

In its latest quarter, Q2 FY22, it was −$1.50.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2021−$15.90n/a
FY2020−$40.20n/a
FY2019−$47.10n/a
FY2018−$97.80n/a
FY2017−$84.90n/a
FY2016−$96.00−219%
FY2015$81.00n/a
FY2014−$37.50n/a
FY2013−$1.50n/a
FY2012−$24.00n/a
FY2011−$42.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY22−$1.50n/a−$7.50
Q1 FY22−$1.20n/a−$9.00
Q4 FY21−$0.90n/a−$15.90
Q3 FY21−$3.90n/a−$23.40
Q2 FY21−$3.00n/a−$29.70
Q1 FY21−$8.10n/a−$37.20
Q4 FY20−$8.40n/a−$40.20
Q3 FY20−$10.20n/a−$41.10
Q2 FY20−$10.50n/a−$38.40
Q1 FY20−$11.10n/a−$41.70
Q4 FY19−$9.30n/a−$47.10
Q3 FY19−$7.50n/a−$69.30

Against its peers

Companies in Healthcare nearest ASTROTECH's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ASTCASTROTECHn/m
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on ASTROTECH

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.